Zevra Therapeutics, Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-2M
Free Cash Flow
$-2M
Investing Cash Flow
$18M
Financing Cash Flow
$12M
Capex
$835K
Acquisitions
$0
Stock Buybacks
$0
Stock-Based Comp
$13M
Debt Issued
$0
Debt Repaid
$0
D&A
$4M
SBC Allocated Expense
$13M
SBC Unrecognized Cost
$9M